Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 128

1.

N-acetylcysteine for antioxidant therapy: pharmacology and clinical utility.

Dodd S, Dean O, Copolov DL, Malhi GS, Berk M.

Expert Opin Biol Ther. 2008 Dec;8(12):1955-62. doi: 10.1517/14728220802517901 . Review.

PMID:
18990082
2.

[Antioxidant treatment with N-acetylcysteine and vitamin C in patients with chronic bronchitis].

Lukas R, Schärling B, Schultze-Werninghaus G, Gillissen A.

Dtsch Med Wochenschr. 2005 Mar 18;130(11):563-7. German.

PMID:
15761783
3.

Existing and potential therapeutic uses for N-acetylcysteine: the need for conversion to intracellular glutathione for antioxidant benefits.

Rushworth GF, Megson IL.

Pharmacol Ther. 2014 Feb;141(2):150-9. doi: 10.1016/j.pharmthera.2013.09.006. Epub 2013 Sep 28. Review.

PMID:
24080471
4.
6.

The use of N-acetylcysteine in intensive care.

Atkinson MC.

Crit Care Resusc. 2002 Mar;4(1):21-7.

PMID:
16573399
7.

N-acetylcysteine in the treatment of psychiatric disorders: current status and future prospects.

Minarini A, Ferrari S, Galletti M, Giambalvo N, Perrone D, Rioli G, Galeazzi GM.

Expert Opin Drug Metab Toxicol. 2017 Mar;13(3):279-292. doi: 10.1080/17425255.2017.1251580. Epub 2016 Nov 2. Review.

PMID:
27766914
8.

The administration of N-acetylcysteine causes a decrease in prothrombin time in patients with paracetamol overdose but without evidence of liver impairment.

Lucena MI, López-Torres E, Verge C, Andrade RJ, Puche MJ, Seoane J, de la Cuesta FS.

Eur J Gastroenterol Hepatol. 2005 Jan;17(1):59-63.

PMID:
15647642
9.

The effect of high dose of N-acetylcysteine in lupus nephritis: a case report and literature review.

Tewthanom K, Janwitayanujit S, Totemchockcyakarn K, Panomvana Na Ayudhya D.

J Clin Pharm Ther. 2010 Aug;35(4):483-5. doi: 10.1111/j.1365-2710.2009.01108.x. Review.

PMID:
20831550
10.

Detrimental effects of N-acetylcysteine plus desferoxamine combination in an experimental nephrotic syndrome model.

Bulucu F, Oktenli C, Kenar L, Koc B, Ocal R, Karadurmus N, Inal V, Yamanel L, Sanisoglu YS, Aydin A.

Int J Toxicol. 2007 Nov-Dec;26(6):525-32.

PMID:
18066968
11.

N-acetylcysteine.

[No authors listed]

Altern Med Rev. 2000 Oct;5(5):467-71.

12.
13.

N-acetylcysteine in psychiatry: current therapeutic evidence and potential mechanisms of action.

Dean O, Giorlando F, Berk M.

J Psychiatry Neurosci. 2011 Mar;36(2):78-86. doi: 10.1503/jpn.100057. Review.

14.

N-acetylcysteine and Unverricht-Lundborg disease: variable response and possible side effects.

Edwards MJ, Hargreaves IP, Heales SJ, Jones SJ, Ramachandran V, Bhatia KP, Sisodiya S.

Neurology. 2002 Nov 12;59(9):1447-9.

PMID:
12427904
15.

The role of glutathione-S-transferase polymorphisms on clinical outcome of ALI/ARDS patient treated with N-acetylcysteine.

Moradi M, Mojtahedzadeh M, Mandegari A, Soltan-Sharifi MS, Najafi A, Khajavi MR, Hajibabayee M, Ghahremani MH.

Respir Med. 2009 Mar;103(3):434-41. doi: 10.1016/j.rmed.2008.09.013. Epub 2008 Nov 7.

16.

Oral N-acetylcysteine attenuates pulmonary emphysema and alveolar septal cell apoptosis in smoking-induced COPD in rats.

Cai S, Chen P, Zhang C, Chen JB, Wu J.

Respirology. 2009 Apr;14(3):354-9. doi: 10.1111/j.1440-1843.2009.01511.x.

PMID:
19341424
17.

Prevention of ifosfamide nephrotoxicity by N-acetylcysteine: clinical pharmacokinetic considerations.

Chen N, Aleksa K, Woodland C, Rieder M, Koren G.

Can J Clin Pharmacol. 2007 Summer;14(2):e246-50. Epub 2007 Jul 24. Review.

PMID:
17652768
18.

Protection against pulmonary O2 toxicity by N-acetylcysteine.

Wagner PD, Mathieu-Costello O, Bebout DE, Gray AT, Natterson PD, Glennow C.

Eur Respir J. 1989 Feb;2(2):116-26.

PMID:
2703040
19.

A minireview on N-acetylcysteine: An old drug with new approaches.

Elbini Dhouib I, Jallouli M, Annabi A, Gharbi N, Elfazaa S, Lasram MM.

Life Sci. 2016 Apr 15;151:359-63. doi: 10.1016/j.lfs.2016.03.003. Epub 2016 Mar 2. Review.

PMID:
26946308
20.

N-acetylcysteine slows down ageing and increases the life span of Drosophila melanogaster.

Brack C, Bechter-Thüring E, Labuhn M.

Cell Mol Life Sci. 1997 Dec;53(11-12):960-6.

PMID:
9447249

Supplemental Content

Support Center